These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 12009655)
41. Prolongation of skin allograft survival after neonatal injection of donor bone marrow and epidermal cells. Petit F; Minns AB; Nazzal JA; Hettiaratchy SP; Lantieri LA; Randolph MA; Lee WP Plast Reconstr Surg; 2004 Jan; 113(1):270-6. PubMed ID: 14707646 [TBL] [Abstract][Full Text] [Related]
42. Augmented survival of purified islet xeno- and allografts with reduced numbers. Gotoh M; Maki T; Porter J; Monaco AP Transplant Proc; 1987 Feb; 19(1 Pt 2):984. PubMed ID: 3152654 [No Abstract] [Full Text] [Related]
43. Long-term survival of islet allografts in diabetic rats treated with FK 506. Tze WJ; Tai J; Cheung SS; Murase N; Ricordi C; Starzl TE Transplant Proc; 1991 Dec; 23(6):3208-10. PubMed ID: 1721411 [No Abstract] [Full Text] [Related]
44. Induction of donor-specific tolerance to rat cardiac allografts by intrathymic inoculation of bone marrow. Odorico JS; Barker CF; Posselt AM; Naji A Surgery; 1992 Aug; 112(2):370-6; discussion 376-7. PubMed ID: 1641776 [TBL] [Abstract][Full Text] [Related]
45. Major impact of engraftment site on early functional outcome of discordant xenoislet grafts from a large animal donor. Troppmann C; Papalois BE; Gruessner AC; Nakhleh RE; Gruessner RW Transplant Proc; 1997 Jun; 29(4):2107-8. PubMed ID: 9193548 [No Abstract] [Full Text] [Related]
47. Prolongation of survival of donor-strain islet xenografts (rat-->mouse) by intrathymic inoculation of xenogeneic islet and bone marrow cells. Mayo GL; Posselt AM; Barker CF; Rostami S; Mayo SP; Campos L; Naji A Transplantation; 1994 Jul; 58(1):107-9. PubMed ID: 8036697 [No Abstract] [Full Text] [Related]
48. Flt3-L augments the engraftment of donor-derived bone marrow cells when combined with sublethal irradiation and costimulatory (CD28/B7 and CD40/CD40L) blockade. Woodward JE; Salam A; Logar AJ; Schaefer AT; Rao AS Cell Transplant; 2002; 11(2):147-59. PubMed ID: 12099638 [TBL] [Abstract][Full Text] [Related]
49. Retransplantation of rat islet allografts following residence in an interim host. Markmann JF; Markmann DP; Balshi JD; Naji A Transplant Proc; 1987 Feb; 19(1 Pt 2):940-1. PubMed ID: 3152644 [No Abstract] [Full Text] [Related]
50. Transplantation tolerance to rat cardiac and islet allografts by posttransplant intrathymic inoculation of soluble alloantigens. Ohajekwe OA; Chowdhury NC; Fiedor PS; Hardy MA; Oluwole SF Transplantation; 1995 Nov; 60(10):1139-43. PubMed ID: 7482722 [TBL] [Abstract][Full Text] [Related]
51. Ultraviolet ray direct irradiation of pancreatic islets before transplantation. Rossi M; Dellagiacoma G; Castagna M; Radin S; Vecchioni R Transplant Proc; 1994 Dec; 26(6):3480-1. PubMed ID: 7998236 [No Abstract] [Full Text] [Related]
52. Prolongation of rat islet allograft survival by treatment with monoclonal antibodies against VLA-4 and LFA-1. Yang H; Issekutz TB; Wright JR Transplantation; 1995 Jul; 60(1):71-6. PubMed ID: 7624946 [TBL] [Abstract][Full Text] [Related]
53. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides. Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717 [TBL] [Abstract][Full Text] [Related]
54. Mixed xenogeneic chimerism (mouse+rat-->mouse) to induce donor-specific tolerance to sequential or simultaneous islet xenografts. Li H; Ricordi C; Demetris AJ; Kaufman CL; Korbanic C; Hronakes ML; Ildstad ST Transplantation; 1994 Feb; 57(4):592-8. PubMed ID: 8116047 [TBL] [Abstract][Full Text] [Related]
55. Islet graft primary nonfunction and its prevention. Arita S; Smith CV; Nagai T; Sakamoto Y; Maruyama M; Mullen Y Transplant Proc; 2000 Nov; 32(7):1667. PubMed ID: 11119883 [No Abstract] [Full Text] [Related]
56. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen. Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294 [TBL] [Abstract][Full Text] [Related]
57. The reversed paradigm of chimerism induction: Donor conditioning with recipient-derived bone marrow cells as a novel approach for tolerance induction in vascularized composite allotransplantation. Siemionow M; Rampazzo A; Gharb BB; Cwykiel J; Klimczak A; Madajka M; Nasir S; Bozkurt M Microsurgery; 2016 Nov; 36(8):676-683. PubMed ID: 26990895 [TBL] [Abstract][Full Text] [Related]
58. Recipient bone marrow-derived stromal cells prolong graft survival in a rat hind limb allotransplantation model. Ikeguchi R; Kakinoki R; Ohta S; Oda H; Yurie H; Kaizawa Y; Mitsui H; Aoyama T; Toguchida J; Matsuda S Microsurgery; 2017 Sep; 37(6):632-640. PubMed ID: 27859595 [TBL] [Abstract][Full Text] [Related]
59. Donor hematopoietic progenitor cells in nonmyeloablated rat recipients of allogeneic bone marrow and liver grafts. Sakamoto T; Ye Q; Lu L; Demetris AJ; Starzl TE; Murase N Transplantation; 1999 Mar; 67(6):833-40. PubMed ID: 10199731 [TBL] [Abstract][Full Text] [Related]
60. The difficulty of eliminating donor leukocyte microchimerism in rat recipients bearing established organ allografts. Kiyomoto T; Toyokawa H; Nakao A; Kaizu T; Demetris AJ; Starzl TE; Murase N Transplantation; 2006 Feb; 81(3):438-44. PubMed ID: 16477232 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]